Dr. Herbert Hurwitz Joins Scientific Advisory Board At Threshold
July 24, 2008 08:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., July 24, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that Herbert Hurwitz, M.D. has joined the Company's Scientific Advisory Board...
Threshold Pharmaceuticals Presents Encouraging Interim Results From a Phase 1 Clinical Trial of TH-302 for Solid Tumors At AACR Conference On Translational Medicine
July 22, 2008 08:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., July 22, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced a presentation on its clinical stage hypoxia-activated prodrug, TH-302, at the...
Threshold Pharmaceuticals Announces $18 Million Private Equity Financing
July 10, 2008 17:22 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., July 10, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that it has entered into a purchase agreement with a select group of investors...
Threshold Pharmaceuticals' Request to Transfer to NASDAQ Capital Market Approved
June 16, 2008 16:30 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., June 16, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (THLD) today announced that it has received approval from the NASDAQ Listing Qualifications Panel (the Panel) to...
Threshold Pharmaceuticals Reports First Quarter 2008 Financial Results
May 07, 2008 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., May 7, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the first quarter ended March 31, 2008.
The net loss for the...
Threshold Pharmaceuticals Received Anticipated NASDAQ Staff Determination Letter
April 18, 2008 08:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 18, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that on April 17, 2008, it received a Staff Determination Letter from NASDAQ...
Multiple Presentations On Oncology Pipeline At the 2008 American Association for Cancer Research Annual Meeting
April 14, 2008 08:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 14, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced three presentations regarding its hypoxia-activated prodrug (HAP) platform, which...
Threshold Pharmaceuticals Announces Multiple Presentations On Oncology Pipeline At the 2008 American Association for Cancer Research Annual Meeting
April 11, 2008 08:30 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 11, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple presentations regarding its oncology pipeline, which includes three...
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results
March 06, 2008 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 6, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the fourth quarter and the year ended December 31,...
Threshold Pharmaceuticals to Present At BIO CEO & Investor Conference
February 11, 2008 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Feb. 11, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that Barry Selick, chief executive officer of Threshold, will present at the BIO...